富血小板血漿市場規模、佔有率、成長分析，按類型、來源、應用、最終用戶、地區 - 產業預測，2024-2031 年

2022年，全球富血小板血漿市場規模為4.7853億美元，從2023年的5.3978億美元成長到2031年的14.1479億美元，預計在複合年成長率預測期內（2024-2031年）將成長。為12.8%。

富血小板血漿（PRP）注射市場作為治療方法各種疾病的有效方法，尤其是脫髮和運動損傷，正在迅速普及。這種創新手術利用患者自身的血球來促進目標區域的癒合和恢復。事實證明，PRP 注射可有效解決肌肉骨骼損傷，顯著加快恢復時間，減輕疼痛，並促進網球肘和跳高膝等慢性疾病更快恢復活動。 PRP 在外科手術和再生醫學的應用不斷增加，為廣泛的醫學研究鋪平了道路，並進一步推動市場成長。這一趨勢的推動因素是運動傷害發生率的增加以及 PRP 在牙科和牙周手術中的應用不斷增加。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 專利分析
• 案例研究

按類型分類的富血小板血漿市場規模和複合年成長率（2024-2031）

• 市場概況
• 純富血小板血漿 (P-PRP)
• 含有白血球 (L-PRP) 的富含血小板血漿
• 含白血球纖維蛋白 (L-PRF)
• 其他

依來源地和複合年成長率分類的富血小板血漿市場規模（2024-2031）

• 市場概況
• 自體富血小板血漿
• 同種異體富血小板血漿
• 同種異體富血小板血漿

按應用和複合年成長率分類的富血小板血漿市場規模（2024-2031）

• 市場概況
• 整形外科和脊椎外科
• 整容手術及美容
• 一般外科
• 神經外科
• 其他

富血小板血漿市場規模：依最終用戶和複合年成長率（2024-2031）

• 市場概況
• 醫院和診所
• 調查機構
• 其他

富血小板血漿市場規模與複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Harvest Technology（USA）
• Stryker Corporation（USA）
• Zimmer Biomet（USA）
• Arthrex Inc.（USA）
• Terumo BCT Inc.（USA）
• Celling BioSciences Inc.（USA）
• APEX Biologix（USA）
• Juventix Regenerative Medical, LLC（Italy）
• Dr. PRP USA LLC（USA）
• Ycellbio Medical Co., Ltd.（South Korea）
• EmCyte Corporation（USA）
• Regen Lab SA（Switzerland）
• Zimmer Biomet（USA）
• Arthrex Inc.（USA）
• Terumo BCT Inc.（USA）
• Celling BioSciences Inc.（USA）

結論和建議

Global Platelet Rich Plasma Market size was valued at USD 478.53 million in 2022 and is poised to grow from USD 539.78 million in 2023 to USD 1414.79 million by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).

The market for platelet-rich plasma (PRP) injections is experiencing a surge in popularity as effective treatments for various conditions, particularly hair loss and sports injuries. This innovative procedure utilizes the patient's own blood cells to enhance healing and recovery in targeted areas. PRP injections have demonstrated efficacy in addressing musculoskeletal injuries, significantly accelerating recovery times, reducing pain, and facilitating quicker returns to activity for chronic conditions like tennis elbow and jumper's knee. The rising adoption of PRP in surgical and regenerative medicine has opened avenues for extensive medical research, further fueling market growth. This trend is bolstered by an increasing incidence of sports injuries, as well as the expansion of PRP applications in dental and periodontal surgeries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Rich Plasma market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Rich Plasma Market Segmental Analysis

Global Platelet Rich Plasma Market is segmented by type, origin, application, by end-user and region. Based on type, the market is segmented into pure platelet rich plasma (P-PRP), leukocyte-rich platelet rich plasma (L-PRP), leukocyte-rich fibrin (L-PRF) and others. Based on origin, the market is segmented into autologous PRP, allogeneic PRP and homologous PRP. Based on application, the market is segmented into orthopedic and spinal surgery, cosmetic surgery and aesthetics, general surgery, neurosurgery and others. Based on end-user, the market is segmented into hospitals and clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Rich Plasma Market

The Platelet Rich Plasma (PRP) market is driven by a significant increase in demand for PRP treatments in orthopaedic disorders, musculoskeletal issues, and sports injuries. This surge can be attributed to PRP's ability to harness growth factors that enhance healing processes. As a personalized regenerative medicine approach, PRP is vital in promoting wound healing and restoring tissue, leading to its extensive application in managing conditions like osteonecrosis and post-tooth extraction healing. Additionally, the versatile use of PRP in aesthetic procedures such as skin rejuvenation, acne scar treatment, and alopecia further fuels market growth, owing to its effectiveness in stimulating collagen production and extracellular matrix reconstruction. As various therapeutic advancements are anticipated, the PRP market is poised for robust expansion in the coming years.

Restraints in the Global Platelet Rich Plasma Market

The anticipated growth of the global platelet rich plasma market during the forecast period is likely to face significant challenges due to the increasing fluctuations in the pricing of platelet-rich plasma therapy. Additionally, the market's expansion could be further restricted by concerns related to quality control and the reliability of test results. Furthermore, the necessity for official FDA approval for specific end-use applications adds another layer of complexity, which may hinder overall market development. These factors combine to create a challenging environment that could stifle the potential growth of the platelet rich plasma market in the coming years.

Market Trends of the Global Platelet Rich Plasma Market

The Global Platelet Rich Plasma (PRP) market is witnessing significant growth, largely fueled by its effectiveness in enhancing hair density and promoting hair follicle development. As PRP is derived from the patient's own blood, it presents a compelling advantage due to its safety profile, minimizing risks of infectious diseases. This innovative treatment is increasingly sought after as both a standalone procedure and in conjunction with hair transplants. Despite the mild side effects commonly associated with PRP, ongoing research aims to solidify its efficacy and establish standardized protocols, ensuring optimal patient outcomes while expanding the market's reach across therapeutic applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Platelet Rich Plasma Market Size by Type & CAGR (2024-2031)

• Market Overview
• Pure Platelet Rich Plasma (P-PRP)
• Leukocyte-Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Rich Fibrin (L-PRF)
• Others

Global Platelet Rich Plasma Market Size by Origin & CAGR (2024-2031)

• Market Overview
• Autologous PRP
• Allogeneic PRP
• Homologous PRP

Global Platelet Rich Plasma Market Size by Application & CAGR (2024-2031)

• Market Overview
• Orthopedic and Spinal Surgery
• Cosmetic Surgery and Aesthetics
• General Surgery
• Neurosurgery
• Others

Global Platelet Rich Plasma Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Research Institutes
• Others

Global Platelet Rich Plasma Market Size & CAGR (2024-2031)

• North America (Type, Origin, Application, End-User)
  • USA
  • Canada
• Europe (Type, Origin, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Origin, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Origin, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Origin, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Harvest Technology (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celling BioSciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• APEX Biologix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Juventix Regenerative Medical, LLC (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. PRP USA LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ycellbio Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EmCyte Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regen Lab SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celling BioSciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations